Gordon Crofoot

发表论文 47 篇 · 总被引 3394 次 · h-index 23

代表论文

• Clinical targeting of HIV capsid protein with a long-acting small molecule (2020 · Nature · 被引 436)
• Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials (2018 · The Lancet · 被引 385)
• Twice-Yearly Lenacapavir for HIV Prevention in Men and Gender-Diverse Persons (2024 · New England Journal of Medicine · 被引 261)
• Efficacy and safety of switching to fixed-dose bictegravir, emtricitabine, and tenofovir alafenamide from boosted protease inhibitor-based regimens in virologically suppressed adults with HIV-1: 48 week results of a randomised, open-label, multicentre, phase 3, non-inferiority trial (2018 · The Lancet HIV · 被引 182)
• Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trial (2022 · The Lancet HIV · 被引 107)
• Phase 2/3 Trial of Molnupiravir for Treatment of Covid-19 in Nonhospitalized Adults (2021 · NEJM Evidence · 被引 99)